There are effective treatments for substance use disorders (SUDs), though they do not work for all patients and efficacy decreases over the long-term. Thus, there is an urgent need for new therapeutic options. This workshop will highlight research to support the development of safe and effective digital therapeutics (DTx), discuss strategies to accelerate their delivery to patients, and improve SUD treatment outcomes. DTx, a subset of digital health, consists of high-quality software programs to prevent, manage, or treat medical conditions. DTx that meet the definition of a medical device go through an FDA regulatory review process to be legally marketed in the US. The ultimate goal of this workshop is to illuminate NIH-supported and FDA-authorized DTx options for patients with SUDs.
This training is part of the Advances in Technology in the Addiction Profession eight-part series offered by NAADAC.
Beginning level courses introduce learners to a content area; include information about a condition, treatment method, or issue; and involve learning and comprehending content.
A Certificate of Completion for 1.5 CEs is available by participating in this specialty online training and passing an online CE quiz. Those who successfully complete the full series and pass all eight CE quizzes for this eight-part series will be eligible to apply for the Advances in Technology in the Addiction Profession Certificate. Access to the online CE quiz will be in your NAADAC profile after registration.
More information on this training is available at https://www.naadac.org/technology-series-2021-session-one.
This training could be applied to multiple areas of the Alaska Qualified Addictions Professional (QAP) certification. Contact the Alaska Commission for Behavioral Health Certification (Ask for Dabney Van Liere, Executive Director) at 907-332-4333 or email email@example.com for specific information.